These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 7715748)

  • 21. Myasthenia gravis and myasthenic syndromes.
    Engel AG
    Ann Neurol; 1984 Nov; 16(5):519-34. PubMed ID: 6095730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myasthenic syndromes.
    Farrugia ME
    J R Coll Physicians Edinb; 2011 Mar; 41(1):43-7; quiz 48. PubMed ID: 21365067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A congenital myasthenic syndrome refractory to acetylcholinesterase inhibitors.
    Triggs WJ; Beric A; Butler IJ; Roongta SM
    Muscle Nerve; 1992 Mar; 15(3):267-72. PubMed ID: 1313543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal neuromuscular transmission in an infantile myasthenic syndrome.
    Albers JW; Faulkner JA; Dorovini-Zis K; Barald KF; Must RE; Ball RD
    Ann Neurol; 1984 Jul; 16(1):28-34. PubMed ID: 6087719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Congenital myasthenic syndrome].
    Araga S
    Nihon Rinsho; 2008 Jun; 66(6):1177-80. PubMed ID: 18540366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital myasthenic syndromes: gene mutation.
    Neuromuscul Disord; 1998 Oct; 8(7):XII-XIII. PubMed ID: 9829287
    [No Abstract]   [Full Text] [Related]  

  • 27. Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor.
    Engel AG; Nagel A; Walls TJ; Harper CM; Waisburg HA
    Muscle Nerve; 1993 Dec; 16(12):1284-92. PubMed ID: 8232383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents.
    Bhattacharyya BJ; Day JW; Gundeck JE; Leonard S; Wollmann RL; Gomez CM
    Synapse; 1997 Dec; 27(4):367-77. PubMed ID: 9372559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical neurophysiology of disorders of the neuromuscular junction.
    Sanders DB
    J Clin Neurophysiol; 1993 Apr; 10(2):167-80. PubMed ID: 8389381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic aspects of myasthenia gravis].
    Friedli WG
    Schweiz Rundsch Med Prax; 1989 Sep; 78(38):1037-44. PubMed ID: 2552554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel.
    Engel AG; Uchitel OD; Walls TJ; Nagel A; Harper CM; Bodensteiner J
    Ann Neurol; 1993 Jul; 34(1):38-47. PubMed ID: 7685992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities].
    Yoshimura T; Motomura M; Tsujihata M
    Brain Nerve; 2011 Jul; 63(7):719-27. PubMed ID: 21747142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital myasthenic syndromes: clinical and genetic analysis of 18 patients.
    Abicht A; Müller-Felber W; Fischer P; Jakob I; Kürz L; Rudel R; Mortier W; Pongratz D; Lochmüller H
    Eur J Med Res; 1997 Dec; 2(12):515-22. PubMed ID: 9498929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome.
    Nichols P; Croxen R; Vincent A; Rutter R; Hutchinson M; Newsom-Davis J; Beeson D
    Ann Neurol; 1999 Apr; 45(4):439-43. PubMed ID: 10211467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.
    Chevessier F; Girard E; Molgó J; Bartling S; Koenig J; Hantaï D; Witzemann V
    Hum Mol Genet; 2008 Nov; 17(22):3577-95. PubMed ID: 18718936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurophysiological aspects of diagnosis in neuromuscular transmission defects--an update.
    Stålberg E
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():377-85. PubMed ID: 10689484
    [No Abstract]   [Full Text] [Related]  

  • 38. Monozygous twins with neuromuscular transmission defects at opposite sides of the motor endplate.
    Punga AR; Nygren I; Askmark H; Stålberg EV
    Acta Neurol Scand; 2009 Mar; 119(3):207-11. PubMed ID: 18684214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
    Banwell BL; Ohno K; Sieb JP; Engel AG
    Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
    Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
    Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.